Diagnosing and responding to violations in the positivity assumption
Tóm tắt
The assumption of positivity or experimental treatment assignment requires that observed treatment levels vary within confounder strata. This article discusses the positivity assumption in the context of assessing model and parameter-specific identifiability of causal effects. Positivity violations occur when certain subgroups in a sample rarely or never receive some treatments of interest. The resulting sparsity in the data may increase bias with or without an increase in variance and can threaten valid inference. The parametric bootstrap is presented as a tool to assess the severity of such threats and its utility as a diagnostic is explored using simulated and real data. Several approaches for improving the identifiability of parameters in the presence of positivity violations are reviewed. Potential responses to data sparsity include restriction of the covariate adjustment set, use of an alternative projection function to define the target parameter within a marginal structural working model, restriction of the sample, and modification of the target intervention. All of these approaches can be understood as trading off proximity to the initial target of inference for identifiability; we advocate approaching this tradeoff systematically.
Từ khóa
Tài liệu tham khảo
Robins JM., 1999, In: Proceedings of the American Statistical Association: Section on Bayesian Statistical Science, 6
Wang Y, 2006, Technical Report 211, Division of Biostatistics
Pearl J., 2000, Causality: models, reasoning, and inference
Robins JM., 1998, In: Proceedings of the American Statistical Association. Section on Bayesian Statistical Science 1997, 1
Robins JM., 1999, In: Halloran E and Berry D (eds) Statistical models in epidemiology, the environment, and clinical trials (Minneapolis, MN, 1997), 95
Bembom O, 2007, EJS, 1, 574
Moore KL, 2009, Technical Report 255, Division of Biostatistics
Rosenblum MM, 2001, Int J Biostat, 1, 4
van der Laan MJ, 2003, Technical Report 130, Division of Biostatistics
van der Laan MJ, 2007, Genet Mol Biol, 6
Kish L., 1992, J Official Stat, 8, 183
Bembom O, 2008, Technical Report 230,Division of Biostatstics
Robins JM, 2001, Stat Sinica, 11, 920
Scharfstein DO, 1999, J Am Stat Assoc, 94, 1121
Petersen ML, 2010, Technical report, division of Biostatstics
Johnson VA, 2009, Top HIV Med, 17, 138
Bembom O, 2008, Technical Report 231, Division of Biostatstics
LaLonde RJ., 1986, Am Econ Rev, 76, 604